Considering that the efficacy ICIs requires CD8+ T cells infiltrations in tumor, we performed TIDE analysis based on FUSCC dataset to predict the correlation between DCLK1 expression levels and the responsiveness of ICIs in TNBC patients. This evidence concerns the gene DCLK1 and neoplasm.